CE Holdings (4320) investor relations material

Executive summary

• Achieved record-high revenue and profits in the first quarter, driven by major electronic medical record (EMR) system contract renewals despite a reduction in consolidated scope due to Micron's exclusion.

• Net sales for the quarter ended December 31, 2025, rose 33.2% year-over-year to ¥5,057 million, with operating profit up 68.0% to ¥655 million and profit attributable to owners of parent up 87.3% to ¥376 million.

• Earnings per share increased to ¥22.60 from ¥13.28 year-over-year.

Financial highlights

• Revenue rose 33.2% year-over-year to ¥5,057 million in Q1.

• Operating income increased 68.0% year-over-year to ¥655 million.

• Ordinary income grew 68.4% year-over-year to ¥667 million.

• Net income attributable to parent rose 87.3% year-over-year to ¥376 million.

• Gross profit increased to ¥1,143.8 million from ¥913.3 million year-over-year, while operating profit rose to ¥655.5 million from ¥390.1 million.

• Ordinary profit reached ¥667.2 million, up from ¥396.3 million year-over-year.

• Comprehensive income attributable to owners of parent was ¥375.8 million, up from ¥200.7 million year-over-year.

Outlook and guidance

• Full-year revenue forecast (excluding Micron) is ¥15,000 million, up 1.4% year-over-year.

• Full-year net sales forecast for FY2026 is ¥15,000 million, a 5.3% decrease year-over-year.

• Operating income projected at ¥1,500 million, up 4.5% year-over-year.

• Operating profit for the full year is projected at ¥1,500 million, down 17.1% year-over-year.

• Net income (excluding prior year’s one-time Micron share sale gain) expected to reach a record ¥870 million, up 16.5% year-over-year.

• Profit attributable to owners of parent expected to decline 44.2% to ¥870 million.

• Full-year EPS is forecast at ¥52.28.

• No change from initial guidance.